Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mihail Obrocea, MD
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 71875
Hamilton, Canada
- Site Reference Id/investigator# 71873
Winnipeg, Canada
- Site Reference Id/investigator# 72338
Osijek, Croatia
- Site Reference Id/investigator# 72334
Zagreb, Croatia
- Site Reference Id/investigator# 72345
Bologna, Italy
- Site Reference Id/investigator# 72314
Moscow, Russia
- Site Reference Id/investigator# 71953
Nizhny Novgorod, Russia
- Site Reference Id/investigator# 72315
Saint Petersburg, Russia
- Site Reference Id/investigator# 72342
Saint Petersburg, Russia
- Site Reference Id/investigator# 72368
Badalona - Barcelona, Spain
- Site Reference Id/investigator# 72366
Majadahonda (Madrid), Spain
- Site Reference Id/investigator# 71894
Savannah, Georgia, United States
- Site Reference Id/investigator# 71897
Worcester, Massachusetts, United States
- Site Reference Id/investigator# 71913
Manhasset, New York, United States
- Site Reference Id/investigator# 71895
Chapel Hill, North Carolina, United States
- Site Reference Id/investigator# 71896
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2006
- Primary completion
- 30 Nov 2007
- Completion
- 30 Nov 2007
- Last update posted
- 27 Apr 2012
- Registered enrollment
- 38
- Registry id
- NCT00307827
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.